Two Sigma Advisers’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $26.5K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $28.4M | Sell |
|
|||||
|
2023
Q1 | $49.9M | Buy |
|
|||||
|
2022
Q4 | $21.5M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Buy |
|
|||||
|
2022
Q2 | $1.5M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.62M | Buy |
|
|||||
|
2020
Q2 | $1.5M | Buy |
|
|||||
|
2020
Q1 | $734K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $215K | Sell |
|
|||||
|
2019
Q1 | $571K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $472K | Sell |
|
|||||
|
2018
Q2 | $1.13M | Buy |
|
|||||
|
2018
Q1 | $687K | Buy |
|
|||||
|
2017
Q4 | $343K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $313K | Sell |
|
|||||
|
2015
Q1 | $549K | Buy |
|